References
1. Palchun V.T. Magomedov M.M., Kryukova A.I. Guide to focal infection in otorhinolaryngology. Moscow: GEOTAR-Media, 2015. 224 p. (in Russian)
2. Sagandykova N.S. Features of the microflora of the Palatine tonsils in chronic inflammation. Vestnik KazNMU. 2015; 2: 105-7. (in Russian)
3. Borisova O.Yu., Aleshkin V.A., Pimenova A.S. The microbial composition of the microflora of the oropharynx in patients with tonsillar pathology. Infekcija i immunitet. 2015; 5 (3): 225-32. (in Russian)
4. Aas J.A., Paster B.J., Stokes L.N. Defining the normal bacterial flora of the oral cavity. Journal of clinical microbiology. 2005; 43 (11): 5721–32. DOI: https://www.doi.org/10.1128/JCM.43.11.5721-5732.2005.
5. Berger C., Hug M., Gysin C., et al. Distribution patterns of β- and γ-herpesviruses within Waldeyer’s ring organs. Journal of Medical Virology. 2007; 79: 1147–52.
6. Assadian F., Sandström K., Bondeson K., et al. Distribution and molecular characterization of human adenovirus and Epstein-Barr virus infections in tonsillar lymphocytes isolated from patients diagnosed with tonsillar diseases. PLoS ONE. 2016; 11(5): 1-19. DOI: https://www.doi.org/10.1371/journal.pone.0154814.
7. Astrid A., Bosch T.M., Biesbroek G., et al. Viral and bacterial interactions in the upper respiratory tract. PLOS Pathogens. 2013; 9 (1): 1-12. DOI: https://www.doi.org/10.1371/journal.ppat.1003057.
8. Shchubelko R.V., Zuikova I.N., Shulzhenko A.E. Mucosal immunity of the upper respiratory tract. Immunologiya. 2018; 39 (1): 81–8. (in Russian)
9. Wu R.-Q., Zhang D.-F., Tu E., et al. The mucosal immune system in the oral cavity – an orchestra of T cell diversity. International Journal of Oral Science. 2014; 6: 125–32.
10. Brandtzaeg P. Secretory immunity with special reference to the oral cavity. Journal of Oral Microbiology. 2013; 5: 1-24. DOI:https://www.doi.org/10.3390/proteomes1030275.
11. Dale B.A., Fredericks L.P. Antimicrobial peptides in the oral environment: expression and function in health and disease. Current Issues in Molecular Biology. 2005; 7 (2): 119–33.
12. Davison G., Allgrove J., Gleeson M. Salivary antimicrobial peptides (LL-37 and alpha-defensins HNP1–3), antimicrobial and IgA responses to prolonged exercise. European Journal of Applied Physiology. 2009; 106: 277–84.
13. Fábián T.K., Tibor K.F., Hermann P., et al. Salivary defense proteins: their network and role in innate and acquired oral immunity. Review. International Journal of Molecular Sciences. 2012; 13: 4295-320.
14. Khurshid Z., Naseem M., Sheikh Z. Oral antimicrobial peptides: types and role in the oral cavity. Saudi Pharmaceutical Journal. 2016; 24: 515–24.
15. Immunotherapy in the practice of ENT doctors and therapists. Ed. Simbirtsev A.S., Lavrenova G.V., SPb.: Dialog, 2018. 456 p. (in Russian)
16. Karaulov A.V., Kalyuzhin O.V. Immunotherapy of infectious diseases: problems and prospects. Therapevticheskiy archive. 2013; 11: 100-8. (in Russian)
17. Immunotherapy. 2nd edition, revised and enlarged. Ed. Khaitov R.M., Ataullakhanov R.I., Shulzhenko A.E., Moscow: GEOTAR-Media, 2018. 768 p. (in Russian)
18. Mirzoeva E.Z. Method for selecting informative symptoms of chronic tonsillitis and chronic pharyngitis. Rossijskaja otorinolaringologija. 2015; 2 (75): 60-3. (in Russian)
19. Mirzoeva E.Z. Diagnostic significance of symptoms of chronic tonsillitis and chronic pharyngitis. Verhnevolzhskij medicinskij zhurnal. 2014; 12 (4): 32-6. (in Russian)
20. Shchubelko R.V., Zuikova I.N., Shulzhenko A.E. Human herpesvirus infections: clinical features and treatment options. Russian medical journal. 2018; 8 (1): 39–45.